(Q43814673)
Statements
1 reference
Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months. United Kingdom/Scandinavian Ponalrestat Trial (English)
1 reference
Sundkvist G
1 reference
Armstrong FM
1 reference
Bradbury JE
1 reference
Chaplin C
1 reference
Ellis SH
1 reference
Owens DR
1 reference
Rosén I
1 reference
Sönksen P
1 reference
1 April 1992
1 reference
1 reference
Identifiers
1 reference